Apellis Pharmaceuticals Stock Price History

APLS Stock  USD 26.33  0.57  2.12%   
If you're considering investing in Apellis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Apellis Pharmaceuticals stands at 26.33, as last reported on the 26th of February, with the highest price reaching 28.14 and the lowest price hitting 26.28 during the day. Apellis Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1 % return per unit of standard deviation over the last 3 months. Apellis Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Apellis Pharmaceuticals' mean deviation of 2.11, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide.
  
Apellis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1021

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAPLS

Estimated Market Risk

 3.22
  actual daily
28
72% of assets are more volatile

Expected Return

 -0.33
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Apellis Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Apellis Pharmaceuticals by adding Apellis Pharmaceuticals to a well-diversified portfolio.

Apellis Pharmaceuticals Stock Price History Chart

There are several ways to analyze Apellis Stock price data. The simplest method is using a basic Apellis candlestick price chart, which shows Apellis Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 2, 202435.42
Lowest PriceFebruary 26, 202526.33

Apellis Pharmaceuticals February 26, 2025 Stock Price Synopsis

Various analyses of Apellis Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Apellis Stock. It can be used to describe the percentage change in the price of Apellis Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Apellis Stock.
Apellis Pharmaceuticals Price Action Indicator(1.17)
Apellis Pharmaceuticals Accumulation Distribution 115,797 
Apellis Pharmaceuticals Price Daily Balance Of Power(0.31)
Apellis Pharmaceuticals Price Rate Of Daily Change 0.98 

Apellis Pharmaceuticals February 26, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Apellis Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Apellis Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Apellis Stock and then apply it to test your longer-term investment strategies against Apellis.

Apellis Stock Price History Data

OpenHighLowCloseVolume
02/26/2025 27.20  28.14  26.28  26.33  1,751,893 
02/25/2025 27.68  27.68  26.56  26.90  1,805,145 
02/24/2025 27.51  27.70  26.95  27.41  1,544,775 
02/21/2025 28.68  28.98  27.46  27.52  1,335,382 
02/20/2025 28.54  28.92  27.92  28.35  1,610,664 
02/19/2025 27.89  28.46  27.89  28.39  1,042,119 
02/18/2025 27.55  28.59  27.45  28.18  1,351,259 
02/14/2025 27.77  28.23  27.02  27.40  1,287,866 
02/13/2025 28.67  28.68  26.84  27.46  2,441,095 
02/12/2025 27.82  28.54  27.61  28.51  925,426 
02/11/2025 28.68  29.14  28.37  28.53  794,818 
02/10/2025 29.69  29.69  28.55  28.68  1,816,880 
02/07/2025 30.00  30.26  29.03  29.39  880,483 
02/06/2025 30.39  30.53  29.53  30.20  1,413,367 
02/05/2025 29.17  30.60  29.08  30.37  1,988,990 
02/04/2025 28.59  29.13  28.23  28.78  1,521,256 
02/03/2025 28.36  28.83  27.91  28.49  1,502,024 
01/31/2025 30.30  30.60  28.97  29.01  1,459,378 
01/30/2025 29.70  30.50  29.41  30.39  1,070,153 
01/29/2025 29.29  29.81  29.11  29.47  1,178,488 
01/28/2025 29.97  30.11  28.72  29.28  2,589,526 
01/27/2025 30.13  30.80  29.36  29.79  1,669,572 
01/24/2025 30.74  30.91  29.67  30.00  1,530,766 
01/23/2025 30.24  31.17  30.23  30.76  1,345,264 
01/22/2025 30.02  30.84  29.96  30.39  1,315,469 
01/21/2025 30.26  30.52  29.39  30.13  1,461,293 
01/17/2025 30.03  30.35  29.61  29.94  1,510,922 
01/16/2025 29.15  30.12  29.15  29.73  1,344,132 
01/15/2025 28.33  30.13  28.25  29.03  2,088,859 
01/14/2025 29.25  29.25  27.61  27.69  1,695,248 
01/13/2025 28.58  29.67  27.63  28.59  3,671,261 
01/10/2025 30.00  30.38  27.35  27.44  3,958,693 
01/08/2025 34.30  34.48  32.96  33.00  1,621,071 
01/07/2025 34.53  35.57  33.83  34.63  1,852,633 
01/06/2025 33.68  35.14  33.36  34.38  4,122,859 
01/03/2025 33.24  34.15  33.16  33.46  2,742,562 
01/02/2025 32.32  33.50  31.87  33.16  1,219,736 
12/31/2024 32.10  32.74  31.43  31.91  977,704 
12/30/2024 32.13  32.50  31.88  31.90  3,050,175 
12/27/2024 32.86  33.33  32.44  32.68  942,145 
12/26/2024 33.05  33.23  32.33  32.96  1,062,450 
12/24/2024 33.21  33.39  32.50  33.32  437,759 
12/23/2024 33.35  33.83  32.79  33.21  1,256,144 
12/20/2024 33.16  34.27  32.89  33.21  3,733,222 
12/19/2024 34.13  34.25  32.88  33.14  3,052,761 
12/18/2024 34.53  35.71  33.73  34.02  1,691,945 
12/17/2024 32.98  34.83  32.74  34.53  2,328,655 
12/16/2024 33.19  34.98  32.71  33.66  5,345,242 
12/13/2024 32.60  33.50  31.76  33.19  5,506,929 
12/12/2024 33.53  34.10  32.30  32.74  2,991,194 
12/11/2024 34.92  34.97  33.97  34.00  1,359,624 
12/10/2024 35.22  35.35  34.21  34.64  1,193,881 
12/09/2024 33.80  35.72  33.35  35.02  5,323,498 
12/06/2024 33.74  34.37  33.16  33.49  2,350,326 
12/05/2024 33.97  34.23  32.67  33.45  5,180,081 
12/04/2024 34.62  34.76  33.76  34.13  1,139,075 
12/03/2024 35.01  35.38  33.82  34.63  3,674,912 
12/02/2024 33.95  35.53  33.60  35.42  2,148,378 
11/29/2024 34.14  34.69  33.78  33.93  1,134,980 
11/27/2024 33.09  34.40  32.77  34.14  2,044,518 
11/26/2024 32.29  32.98  31.80  32.63  3,302,078 

About Apellis Pharmaceuticals Stock history

Apellis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Apellis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Apellis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Apellis Pharmaceuticals stock prices may prove useful in developing a viable investing in Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Apellis Pharmaceuticals, Inc. was incorporated in 2009 and is based in Waltham, Massachusetts. Apellis Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 476 people.

Apellis Pharmaceuticals Stock Technical Analysis

Apellis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Apellis Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Apellis Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module

Apellis Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Apellis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Apellis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Apellis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Apellis Stock Analysis

When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.